Viewing Study NCT05526131



Ignite Creation Date: 2024-05-06 @ 6:02 PM
Last Modification Date: 2024-10-26 @ 2:40 PM
Study NCT ID: NCT05526131
Status: COMPLETED
Last Update Posted: 2022-09-02
First Post: 2022-08-31

Brief Title: BDNF Level and val66met Polymorphism of Brain Derived Neurotropic Factor Gene in Patients With T2DM and Depression
Sponsor: Kasr El Aini Hospital
Organization: Kasr El Aini Hospital

Study Overview

Official Title: Brain Derived Neurotropic Factor Level and val66met Polymorphism of Brain Derived Neurotropic Factor Gene in Patients With Type Two Diabetes Mellitus and Depression
Status: COMPLETED
Status Verified Date: 2022-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study aimed to evaluate the relation between the levels of Brain Derived Neurotropic Factor BDNF and val66met polymorphism of BDNF gene and the presence of depression in type 2 diabetes In addition to studying the relationship between BDNF level and val66met polymorphism of its gene and assessing relation between BDNF level and obesity
Detailed Description: The study included 88 type 2 diabetic patients which are further divided into two groups depressed and non-depressed Depression was assessed by Hamilton Depression Rating Scale HAM-D and structured clinical interview for DSM-IV Axis disorder SCID-I for diagnosing depression and exclusion of other psychiatric disorders Genotyping was performed by using Real Time-PCR TaqMan probes

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None